[Therapeutic drug monitoring of fluoroquinolone].
Matsumoto
F
F
Department of Internal Medicine, Kanagawa Prefectural Nursing and Hygienic School Hospital.
Takahashi
T
T
Morita
M
M
D000890:Anti-Infective Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine; D001646:Bile / Q000378:metabolism; D001681:Biological Assay; D001682:Biological Availability; D002851:Chromatography, High Pressure Liquid; D002939:Ciprofloxacin / Q000097:blood / Q000493:pharmacokinetics / Q000652:urine; D015365:Enoxacin / Q000097:blood / Q000493:pharmacokinetics / Q000652:urine; D024841:Fluoroquinolones; D006801:Humans; D009287:Naphthyridines; D009643:Norfloxacin / Q000097:blood / Q000493:pharmacokinetics / Q000652:urine; D015242:Ofloxacin / Q000097:blood / Q000493:pharmacokinetics / Q000652:urine; D015363:Quinolones; D013183:Sputum / Q000378:metabolism
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D009287:Naphthyridines; D015363:Quinolones; D015365:Enoxacin; D002939:Ciprofloxacin; D015242:Ofloxacin; C055185:tosufloxacin; C053091:lomefloxacin; D009643:Norfloxacin